18F-FDG PET "Metabolic Response" to Neoadjuvant Systemic Therapy for Breast Cancer: Quo Vadis?

被引：0
|
作者：
Gebhart, Geraldine [1 ]
机构：
[1] Univ Libre Bruxelles, Hop Univ Bruxelles, Inst Jules Bordet, Dept Nucl Med, Brussels, Belgium
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷 / 11期
关键词：
CHEMOTHERAPY;
D O I：
10.2967/jnumed.123.266303
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1697 / 1698
页数：2
相关论文
共 50 条
  • [31] 18F-FDG PET/CT metabolic changes in neoadjuvant radiochemotherapy response of locally advanced rectal cancer (LARC)
    Guerra, L.
    Niespolo, R.
    Arosio, M.
    Musarra, M.
    Gardani, G.
    Sironi, S.
    Pasquali, C.
    Marcelli, S.
    Fazio, F.
    Messa, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S271 - S271
  • [32] Evaluation of the response to breast cancer neoadjuvant chemotherapy using 18F-FDG Positron Emission Mammography compared with whole-body 18F-FDG PET.
    Noritake, Mutsumi
    Zenjiro, Sekikawa
    Sugae, Sadatoshi
    Tanabe, Mikiko
    Sakamaki, Kentaro
    Inoue, Tomio
    Ishikawa, Takashi
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [33] METABOLIC MONITORING OF CERVICAL CANCER BY 18F-FDG PET: PREDICTING RESPONSE AND OUTCOME
    Leseur, J.
    Williaume, D.
    Garin, E.
    Louvel, G.
    Le Prise, E.
    Fougerou, C.
    Bouriel, C.
    Leveque, J.
    de Crevoisier, R.
    Devillers, A.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S302 - S302
  • [34] The prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients: ultrasonography versus 18F-FDG PET/CT
    Cakmak, G. Karadeniz
    Emre, A. U.
    Uslu, R.
    Engin, H.
    Bahadir, B.
    Bakkal, B. H.
    BREAST, 2019, 44 : S73 - S73
  • [35] Monitoring Tumour Response to Neoadjuvant Chemotherapy using MRI and 18F-FDG PET/CT in Breast Cancer Subtypes
    Schmitz, A. M. T.
    Pengel, K. E.
    Loo, C. E.
    Vogel, W.
    Wesseling, J.
    Teixeira, S. C.
    Rutgers, E. J. T.
    Olmos, R. A. Valdes
    Sonke, G. S.
    Rodenhuis, S.
    Vrancken-Peeters, M. T. F. D.
    Gilhuijs, K. G. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S266 - S267
  • [36] 18F-FDG PET in detecting primary breast cancer
    Kumar, Rakesh
    Lal, Neena
    Alavi, Abass
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (10) : 1751 - 1751
  • [37] Utility of 18F-FDG PET/CT for the prediction of pathologic complete response in axilla to neoadjuvant chemotherapy in breast cancer
    Michel, Eloise
    Beltjens, Francoise
    Cochet, Alexandre
    Alberini, Jean Louis
    Coutant, Charles
    Jankowski, Clementine
    CANCER RESEARCH, 2023, 83 (05)
  • [38] Combined use of 18F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy
    Pengel, Kenneth E.
    Koolen, Bas B.
    Loo, Claudette E.
    Vogel, Wouter V.
    Wesseling, Jelle
    Lips, Esther H.
    Rutgers, Emiel J. Th.
    Olmos, Renato A. Valdes
    Peeters, Marie Jeanne T. F. D. Vrancken
    Rodenhuis, Sjoerd
    Gilhuijs, Kenneth G. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (08) : 1515 - 1524
  • [39] Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim
    David Groheux
    Sylvie Giacchetti
    Marc Espié
    Domenico Rubello
    Jean-luc Moretti
    Elif Hindié
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 419 - 425
  • [40] Combined use of 18F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy
    Kenneth E. Pengel
    Bas B. Koolen
    Claudette E. Loo
    Wouter V. Vogel
    Jelle Wesseling
    Esther H. Lips
    Emiel J. Th. Rutgers
    Renato A. Valdés Olmos
    Marie Jeanne T. F. D. Vrancken Peeters
    Sjoerd Rodenhuis
    Kenneth G. A. Gilhuijs
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1515 - 1524
12345